Publications by authors named "John Hetherington"

Claim this Profile
A
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial.
Nicholas D James, Matthew R Sydes, Noel W Clarke, Malcolm D Mason, David P Dearnaley, John Hetherington

Lancet· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer.
Malcolm D Mason, Wendy R Parulekar, Matthew R Sydes, Michael Brundage, Peter Kirkbride, John Hetherington

J Clin Oncol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).
Nicholas David James, Melissa R Spears, Noel W Clarke, David P Dearnaley, Johann S De Bono, John Hetherington

Eur Urol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost of service quality improvements: tracking the flow of funds in social franchise networks in Myanmar.
David Bishai, Amnesty LeFevre, Marc Theuss, Matt Boxshall, John D Hetherington

Cost Eff Resour Alloc· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.
Padraig Warde, Malcolm Mason, Keyue Ding, Peter Kirkbride, Michael Brundage, John Hetherington

Lancet· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metronomic chemotherapy dosing-schedules with estramustine and temozolomide act synergistically with anti-VEGFR-2 antibody to cause inhibition of human umbilical venous endothelial cell growth.
Thomas Lam, John W Hetherington, John Greenman, Samantha Little, Anthony Maraveyas

Acta Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From total empiricism to a rational design of metronomic chemotherapy phase I dosing trials.
Thomas Lam, John W Hetherington, John Greenman, Anthony Maraveyas

Anticancer Drugs· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of initially successful trabeculectomy with 5-fluorouracil injections.
Ricardo Suzuki, Christopher J Dickens, Andrew G Iwach, H Dunbar Hoskins, John Hetherington

Ophthalmology· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with new onset haematuria: assessing the discriminant value of clinical information in relation to urological malignancies.
Nicholas Summerton, Sara Mann, Alan S Rigby, Julie Ashley, Sarah Palmer, John W Hetherington

Br J Gen Pract· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of Acucise endopyelotomy in the treatment of ureteropelvic junction obstruction.
Chandra S Biyani, Suks Minhas, James el Cast, David J Almond, Graeme Cooksey, John W Hetherington

Eur Urol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis